Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Neurotech
company
About
Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $35M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 1995
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseases—including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$35M
Neurotech has raised a total of
$35M
in funding over 2 rounds. Their latest funding was raised on
Nov 16, 2006 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 16, 2006 | Series B | $35M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Neurotech is funded by 3 investors.
Mayflower
and Triginta Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Triginta Capital
|
— | Series B |
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
